ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
69,737.20
-2.40%
S&P 500
5,321.41
0.25%
Dow Jones
39,872.99
0.17%
US Dollar vs Yen
156.1855
-0.12%
Brent Oil
82.445
-1.30%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Avadel Pharmaceuticals PLC (AVDL)

  7. Avadel Pharmaceuticals PLC (AVDL) ニュース

AVDL

Avadel Pharmaceuticals (AVDL)

Avadel Pharmaceuticals PLC
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:AVDL
日付受信時刻ニュースソース見出しコード企業名
2024/05/2120 : 04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/05/2120 : 00GlobeNewswire Inc.Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of DirectorsNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/05/1805 : 18Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/05/0905 : 17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/05/0905 : 06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/05/0822 : 16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/05/0821 : 29IH Market NewsU.S. Futures Slightly Dip Amid Corporate Earnings and Quiet Economic Calendar, Oil Prices FallNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/05/0820 : 08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/05/0820 : 00GlobeNewswire Inc.Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial ResultsNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/05/0121 : 00GlobeNewswire Inc.Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 8NASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/04/0121 : 00GlobeNewswire Inc.Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare ConferenceNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/03/0522 : 00GlobeNewswire Inc.Avadel Pharmaceuticals to Present at Upcoming Investor ConferencesNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/03/0505 : 51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/03/0505 : 37GlobeNewswire Inc.Avadel Pharmaceuticals Issues Statement On Patent LitigationNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/03/0420 : 35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/03/0420 : 30GlobeNewswire Inc.Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/03/0420 : 28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/03/0420 : 26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/03/0420 : 24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/02/2622 : 00GlobeNewswire Inc.Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 4NASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/02/1421 : 11Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/02/1407 : 54Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/02/1406 : 39Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/02/1323 : 40Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/02/1222 : 20Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/02/0722 : 00GlobeNewswire Inc.Avadel Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/01/1706 : 36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/01/0821 : 20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/01/0821 : 00GlobeNewswire Inc.Avadel Pharmaceuticals Announces Strong LUMRYZ Launch Performance and Provides Preliminary Fourth Quarter and Full Year 2023 Financial HighlightsNASDAQ:AVDLAvadel Pharmaceuticals PLC
2023/12/3006 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
 Showing the most relevant articles for your search:NASDAQ:AVDL

最近閲覧した銘柄

AMEX
SPY
SPDR S&P 500
NASDAQ
GOOGL
Alphabet
COIN
BTCUSD
Bitcoin
USOTC
BNPQY
BNP Paribas (QX)
AMEX
XLE
Energy Select Sector SPDR
NYSE
JPM
JP Morgan Chase
FX
USDGBP
US Dollar vs Sterling
AMEX
XLV
Health Care Select Sector
USOTC
BASFY
BASF (QX)
NYSE
DIS
Walt Disney
AMEX
XLF
Financial Select Sector
COIN
SOLUSD
Solana
CCOM
US500
US 500
FX
USDJPY
US Dollar vs Yen
FX
USDEUR
US Dollar vs Euro
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有